Caption Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100,000
Closed -$1.29M 1904
2025
Q4
$1.29M Hold
100,000
0.01% 970
2025
Q3
$1.29M Hold
100,000
0.01% 1020
2025
Q2
$1.78M Buy
+100,000
New +$1.74M 0.02% 753
2025
Q1
Sell
-55,000
Closed -$1.64M 1879
2024
Q4
$1.64M Buy
+55,000
New +$1.16M 0.02% 771
2024
Q2
Sell
-243,700
Closed -$3.81M 1401
2024
Q1
$3.81M Buy
243,700
+208,700
+596% +$3.07M 0.06% 359
2023
Q4
$523K Hold
35,000
0.01% 952
2023
Q3
$565K Sell
35,000
-20,400
-37% -$588K 0.01% 906
2023
Q2
$2.3M Buy
55,400
+29,900
+117% +$1.86M 0.04% 467
2023
Q1
$1.53M Sell
25,500
-31,000
-55% -$2.48M 0.03% 521
2022
Q4
$4.14M Buy
+56,500
New +$4.25M 0.06% 351
2022
Q1
Sell
-106,700
Closed -$8.01M 1782
2021
Q4
$8.01M Sell
106,700
-3,800
-3% -$381K 0.09% 312
2021
Q3
$12.8M Sell
110,500
-900
-0.8% -$136K 0.15% 175
2021
Q2
$24.7M Buy
111,400
+7,400
+7% +$1.44M 0.32% 51
2021
Q1
$13.7M Sell
104,000
-8,000
-7% -$1.27M 0.3% 67
2020
Q4
$19.4M Buy
+112,000
New +$15.3M 0.44% 44
2019
Q3
Sell
-55,000
Closed -$3.48M 835
2019
Q2
$3.48M Buy
+55,000
New +$2.79M 0.18% 166

Other funds holding NVCR

Caption Management's NVCR Position: Q2 2024 in Review

Caption Management sold out of NovoCure (NVCR) in Q2 2024, closing a stake of 2,493 shares — an estimated $39K sold.

Caption Management first reported a position in NVCR in Q3 2020 and held it in 6 quarters. The position peaked at $9.59M in Q4 2020. 236 funds tracked by Wall St. Rank hold NVCR as of Q2 2024.

  • Caption Management reported no remaining NovoCure position as of Q2 2024 after selling out during the quarter.
  • Caption Management sold 2,493 NovoCure shares in Q2 2024, an estimated $39K.
  • Caption Management first reported a position in NovoCure in Q3 2020 and held it in 6 quarters.
  • Caption Management's NovoCure position peaked at $9.59M in Q4 2020.
  • 236 funds tracked by Wall St. Rank held NovoCure as of Q2 2024.

Based on Caption Management's 13F filing for Q2 2024, filed 14 Aug 2024.